Page last updated: 2024-09-04

vx 497 and Graft vs Host Disease

vx 497 has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chaturvedi, PR; Decker, CJ; Faust, TJ; Heiser, AD; Ku, G; Moseley, S; Nimmesgern, E	1

Other Studies

1 other study(ies) available for vx 497 and Graft vs Host Disease

Article	Year
The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice. Drugs under experimental and clinical research, 2001, Volume: 27, Issue:3 Topics: Animals; Carbamates; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Graft Rejection; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; IMP Dehydrogenase; Interferon-gamma; Mice; Mice, Inbred Strains; Models, Animal; Phenylurea Compounds; Skin; Skin Transplantation; Spleen	2001

Article

Year

The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.

Drugs under experimental and clinical research, 2001, Volume: 27, Issue:3

Topics: Animals; Carbamates; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Graft Rejection; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; IMP Dehydrogenase; Interferon-gamma; Mice; Mice, Inbred Strains; Models, Animal; Phenylurea Compounds; Skin; Skin Transplantation; Spleen

2001